Literature DB >> 9398736

Resistance of gonadotropin releasing hormone drive to sex steroid-induced suppression in hyperandrogenic anovulation.

T L Daniels1, S L Berga.   

Abstract

Women with hyperandrogenic anovulation (HAA) exhibit increased GnRH drive, as evidenced by a faster LH pulse frequency that slows in response to progestin-induced opioidergic tone. To determine whether increased GnRH-LH drive in HAA reflects altered sex steroid exposure caused by chronic anovulation or is an intrinsic hypothalamic attribute, we compared the pulsatile LH response to oral contraceptive (OC)-induced suppression in seven women with HAA, with that of seven eumenorrheic women (EW). LH levels were determined at 10-min intervals for 12 h after 19-21 days of OC use and 5-7 days after cessation. Testosterone, androstenedione, estradiol, FSH, and LH levels were determined at weekly intervals before, during, and after OC use. LH pulse number/12 h was higher (P < 0.001) in HAA during and after OCs, when compared with that of EW. Mean LH was increased in HAA before, during, and after OCs. Testosterone, androstenedione, and estradiol levels were higher in HAA before OCs, but they decreased to similar levels during OC use in both groups. FSH concentrations were similar before and during OCs but rose more after cessation of OCs in EW. These findings indicate that GnRH drive in HAA is resistant to OC-induced suppression and, therefore, could be an intrinsic hypothalamic attribute.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9398736     DOI: 10.1210/jcem.82.12.4402

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  36 in total

1.  Obesity and sex steroid changes across puberty: evidence for marked hyperandrogenemia in pre- and early pubertal obese girls.

Authors:  Christopher R McCartney; Susan K Blank; Kathleen A Prendergast; Sandhya Chhabra; Christine A Eagleson; Kristin D Helm; Richard Yoo; R Jeffrey Chang; Carol M Foster; Sonia Caprio; John C Marshall
Journal:  J Clin Endocrinol Metab       Date:  2006-11-21       Impact factor: 5.958

Review 2.  Polycystic ovary syndrome: What is it? Pathogenetic enigma and therapeutic dilemma.

Authors:  V Toscano
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

Review 3.  Estrogen-progestagen therapy in the management of the polycystic ovary syndrome.

Authors:  J C Marshall
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

Review 4.  The feasibility of long-term treatment of polycystic ovary syndrome with GnRH-agonists.

Authors:  S L Berga
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

5.  Pathogenic Anti-Müllerian Hormone Variants in Polycystic Ovary Syndrome.

Authors:  Lidija K Gorsic; Gulum Kosova; Brian Werstein; Ryan Sisk; Richard S Legro; M Geoffrey Hayes; Jose M Teixeira; Andrea Dunaif; Margrit Urbanek
Journal:  J Clin Endocrinol Metab       Date:  2017-08-01       Impact factor: 5.958

Review 6.  Hyperandrogenic origins of polycystic ovary syndrome - implications for pathophysiology and therapy.

Authors:  David H Abbott; Daniel A Dumesic; Jon E Levine
Journal:  Expert Rev Endocrinol Metab       Date:  2019-02-15

7.  Maturation of luteinizing hormone (gonadotropin-releasing hormone) secretion across puberty: evidence for altered regulation in obese peripubertal girls.

Authors:  Christopher R McCartney; Kathleen A Prendergast; Susan K Blank; Kristin D Helm; Sandhya Chhabra; John C Marshall
Journal:  J Clin Endocrinol Metab       Date:  2008-10-28       Impact factor: 5.958

8.  Endocrine antecedents of polycystic ovary syndrome in fetal and infant prenatally androgenized female rhesus monkeys.

Authors:  David H Abbott; Deborah K Barnett; Jon E Levine; Vasantha Padmanabhan; Daniel A Dumesic; Steve Jacoris; Alice F Tarantal
Journal:  Biol Reprod       Date:  2008-04-02       Impact factor: 4.285

9.  Acupuncture for ovulation induction in polycystic ovary syndrome: a randomized controlled trial.

Authors:  Julia Johansson; Leanne Redman; Paula P Veldhuis; Antonina Sazonova; Fernand Labrie; Göran Holm; Gudmundur Johannsson; Elisabet Stener-Victorin
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-03-12       Impact factor: 4.310

Review 10.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

Authors:  Robert L Rosenfield; David A Ehrmann
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.